Publications by authors named "Jaci Skidmore"

Introduction: Objective measures of symptom response to integrated complementary approaches in pediatrics are evolving. The purpose of this study was to document the concentration range of salivary neuropeptides in healthy controls and in children with cancer, to explore correlations between serum and salivary measurements for Calcitonin Gene-Related Peptide (CGRP) and Vasoactive Intestinal Polypeptide (VIP), and to determine whether there is a change in these salivary neuropeptide levels in response to integrated mind-body therapies.

Methods: A non-randomized pragmatic study with three phases: Phase 1- Healthy Control Saliva-10 healthy controls provided saliva samples; Phase 2- Cancer Diagnosis Serum-Saliva- 16 mixed-type cancer patients provided blood and saliva samples; Phase 3- Acute Lymphocytic Leukemia (ALL) Saliva Intervention- 12 patients with ALL provided pre- and post-complementary intervention saliva samples.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Jaci Skidmore"

  • - Jaci Skidmore's research primarily focuses on the role of salivary neuropeptides as potential biomarkers in pediatric populations, particularly in the context of integrated therapies for children with health challenges.
  • - In her 2015 study, she explored the concentration ranges of salivary neuropeptides such as CGRP and VIP in healthy children and those with cancer, establishing the importance of these biomarkers in evaluating therapy responses.
  • - The study employed a non-randomized, multi-phase approach, comparing saliva and serum samples from healthy controls and cancer patients, ultimately assessing changes in neuropeptide levels following mind-body therapeutic interventions.